The Patent Finder

Pi Agsciences, Inc.

14 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Plant Health Care, Inc. (to 2025)

0
Ending by 2030
Oct 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 15, 2027
    The maintenance fee for Hypersensitive response elicitor-derived peptides and use thereof (US 11,725,027) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 3 fees due May 12 to 21, 2027 · next May 12
  • 2 fees due Jul 7, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,470,461Hypersensitive response elicitor peptides and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,524,472Elicitor peptides having disrupted hypersensitive response box and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,524,473Elicitor peptides having disrupted hypersensitive response box and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,743,538Elicitor peptides having disrupted hypersensitive response box and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,856,546Hypersensitive response elicitor peptides and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,856,547Hypersensitive response elicitor peptides and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,897,900Hypersensitive response elicitor peptides and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,918,104Elicitor peptides having disrupted hypersensitive response box and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,820,797Elicitor peptides having disrupted hypersensitive response box and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,820,992Hypersensitive response elicitor peptides and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited